company background image
524590 logo

Hemo Organic BSE:524590 Stock Report

Last Price

₹11.56

Market Cap

₹40.1m

7D

6.0%

1Y

49.5%

Updated

21 Dec, 2024

Data

Company Financials

Hemo Organic Limited

BSE:524590 Stock Report

Market Cap: ₹40.1m

524590 Stock Overview

Engages in the manufacture and sale of ayurvedik or Unani pharmaceutical preparations in India. More details

524590 fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health0/6
Dividends0/6

Risk Analysis

Does not have a meaningful market cap (₹40M)

Earnings have declined by 48.5% per year over past 5 years

Makes less than USD$1m in revenue (₹226K)

Highly volatile share price over the past 3 months compared to the Indian market

+ 2 more risks

My Notes

Capture your thoughts, links and company narrative

Hemo Organic Limited Competitors

Kabra Drugs

BSE:524322

₹44.1m

Shamrock Industrial

BSE:531240

₹70.7m

Fabino Enterprises

BSE:543444

₹65.2m

Desh Rakshak Aushdhalaya

BSE:531521

₹66.8m

Price History & Performance

Summary of share price highs, lows and changes for Hemo Organic
Historical stock prices
Current Share Price₹11.56
52 Week High₹15.25
52 Week Low₹6.44
Beta0.13
1 Month Change5.28%
3 Month Change-0.34%
1 Year Change49.55%
3 Year Change57.28%
5 Year Change-20.00%
Change since IPO545.81%

Recent News & Updates

Recent updates

Shareholder Returns

524590IN PharmaceuticalsIN Market
7D6.0%0.8%-4.2%
1Y49.5%39.7%19.1%

Return vs Industry: 524590 exceeded the Indian Pharmaceuticals industry which returned 39.7% over the past year.

Return vs Market: 524590 exceeded the Indian Market which returned 19.1% over the past year.

Price Volatility

Is 524590's price volatile compared to industry and market?
524590 volatility
524590 Average Weekly Movement9.4%
Pharmaceuticals Industry Average Movement6.0%
Market Average Movement6.2%
10% most volatile stocks in IN Market9.0%
10% least volatile stocks in IN Market4.1%

Stable Share Price: 524590's share price has been volatile over the past 3 months compared to the Indian market.

Volatility Over Time: 524590's weekly volatility (9%) has been stable over the past year, but is still higher than 75% of Indian stocks.

About the Company

FoundedEmployeesCEOWebsite
19925Vishwambar Singhwww.hemoorganic.com

Hemo Organic Limited engages in the manufacture and sale of ayurvedik or Unani pharmaceutical preparations in India. It also engages in the manufacturing, trading, and dealing of chemicals, dyes, pigments, auxiliaries, intermediates, heavy and fine chemicals, organic and inorganic chemicals, etc. The company was formerly known as Dinesh Allorga Limited and changed its name to Hemo Organic Limited in August 2013. The company was incorporated in 1992 and is based in Anand, India.

Hemo Organic Limited Fundamentals Summary

How do Hemo Organic's earnings and revenue compare to its market cap?
524590 fundamental statistics
Market cap₹40.07m
Earnings (TTM)-₹3.15m
Revenue (TTM)₹226.00k

177.3x

P/S Ratio

-12.7x

P/E Ratio

Is 524590 overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
524590 income statement (TTM)
Revenue₹226.00k
Cost of Revenue₹153.00k
Gross Profit₹73.00k
Other Expenses₹3.22m
Earnings-₹3.15m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-0.91
Gross Margin32.30%
Net Profit Margin-1,393.81%
Debt/Equity Ratio-313.9%

How did 524590 perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/21 22:08
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Hemo Organic Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution